Elevated kinase activities of SFKs, mainly Src and Yes, were frequently observed in colorectal cancer (CRC), as compared with the normal counterpart, and this has been associated with tumor progression, metastasis, and a poor clinical outcome. This evidence concerns the gene SRC and colorectal carcinoma.